MedPath

Pilot Study Evaluating the Elasticity and Shear Wave Modulus (Stiffness) of the Median Nerve in Patients With Mild to Moderate Idiopathic Carpal Tunnel Syndrome Receiving OMT and Conservative Therapy

Not Applicable
Recruiting
Conditions
Carpal Tunnel Syndrome
Interventions
Other: Conservative treatment
Other: Osteopathic manipulative treatment (OMT)
Registration Number
NCT06150443
Lead Sponsor
Kettering Health Network
Brief Summary

To evaluate and quantify changes in the elasticity and shear wave modulus (stiffness) of the median nerve in patients diagnosed with mild to moderate carpal tunnel syndrome following osteopathic manipulative therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Diagnosis of unilateral or bilateral mild to moderate carpal tunnel syndrome, based on recent EMG findings
Exclusion Criteria
  • History of undergoing recent physical therapy for treatment of carpal tunnel syndrome
  • History of wrist trauma or surgery
  • Hypothyroidism
  • Severe CTS that has progressed to muscle atrophy
  • Systemic disease or condition including but not limited to diabetes mellitus, thyroid disorders, rheumatoid disorders, Paget's bone disease, gout, myxedema, multiple myeloma, acromegaly, hepatic disease, dialysis patients, or other diseases or conditions in which peripheral neuropathies are common.
  • Secondary cause of CTS such as a ganglion cyst, mass, or an accessory muscle shown by US or MRI of the affected wrist.
  • Bifid median nerve as shown by US or MRI of the affected wrist
  • pregnant or recently postpartum

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 3 - Conservative Treatment OnlyConservative treatmentConservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical and Occupational therapy will be excluded from the conservative therapy regimen.
Group 1 - OMT OnlyOsteopathic manipulative treatment (OMT)Osteopathic manipulative treatment will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. The cervical spine will also be treated, with particular attention to the C5-7 levels, all the way to the wrist and hand as the physician sees fit based on the findings of the osteopathic structural exam.
Group 2 - OMT + Conservative TreatmentOsteopathic manipulative treatment (OMT)Will receive Osteopathic manipulative treatment in addition to conservative treatment. Conservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical and Occupational therapy will be excluded from the conservative therapy regimen. Osteopathic manipulative treatment will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. The cervical spine will also be treated, with particular attention to the C5-7 levels, all the way to the wrist and hand as the physician sees fit based on the findings of the osteopathic structural exam.
Group 2 - OMT + Conservative TreatmentConservative treatmentWill receive Osteopathic manipulative treatment in addition to conservative treatment. Conservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical and Occupational therapy will be excluded from the conservative therapy regimen. Osteopathic manipulative treatment will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. The cervical spine will also be treated, with particular attention to the C5-7 levels, all the way to the wrist and hand as the physician sees fit based on the findings of the osteopathic structural exam.
Primary Outcome Measures
NameTimeMethod
Cross-sectional area of median nerve in 3 locationsbaseline, post 2-week treatment, post 4-week treatment, post 6-week treatment

Measured by real-time grayscale ultrasound

Elasticity of median nerve at the carpal tunnel inletbaseline, post 2-week treatment, post 4-week treatment, post 6-week treatment

Measured by shear wave elastography.

Elasticity of the transverse carpal ligamentbaseline, post 2-week treatment, post 4-week treatment, post 6-week treatment

Measured by shear wave elastography.

Elasticity of the subsynovial connective tissue in the carpal tunnelbaseline, post 2-week treatment, post 4-week treatment, post 6-week treatment

Measured by shear wave elastography.

Quick DASH Patient Survey ScoreCompleted at treatment visits (initial, 2 weeks, 4 weeks, and 6 weeks)

This questionnaire asks the patient about their symptoms as well as their ability to perform certain activities. The QuickDASH, published in 2005 in the Journal of Bone and Joint Surgery, is a subset of 11 items from the 30-item DASH and is a self-reported questionnaire in which the response options are presented as 5-point Likert scales. At least 10 of the 11 items must be completed for a score to be calculated and the scores range from 0 (no disability) to 100 (most severe disability). This score was designed be useful in patients with any musculoskeletal disorder of the upper limb.

CTS-6 Evaluation Tool ScoreCompleted at treatment visits (initial, 2 weeks, 4 weeks, and 6 weeks)

The Value Added by Electrodiagnostic Testing in the Diagnosis of Carpal Tunnel Syndrome completed by the clinician. A score \>12 = 0.80 probability of Carpal Tunnel Syndrome and a score \>5 = 0.25 probability of Carpal Tunnel Syndrome.

Secondary Outcome Measures
NameTimeMethod
Sensory Distal LatencyBaseline and at 8 weeks (end of study)

Time it takes for an impulse to traverse the segment nearest the muscle.

Motor Distal LatencyBaseline and at 8 weeks (end of study)

Time it takes for an impulse to traverse the segment nearest the muscle.

Trial Locations

Locations (1)

Kettering Health

🇺🇸

Dayton, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath